V. Helicobacter pylori therapy: Effect on peptic ulcer disease
- 1 April 1991
- journal article
- clinical trial
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 6 (2), 131-137
- https://doi.org/10.1111/j.1440-1746.1991.tb01452.x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Metronidazole resistance in Helicobacter pyloriThe Lancet, 1990
- BISMUTH TOXICITY—A REASSESSMENTJournal of Clinical Pharmacy & Therapeutics, 1989
- LOWERED GASTRIN AND GASTRIC ACIDITY AFTER ERADICATION OF CAMPYLOBACTER PYLORI IN DUODENAL ULCERThe Lancet, 1989
- Epidemiologie und Therapie der Campylobacter-pylori-InfektionDeutsche Medizinische Wochenschrift (1946), 1989
- Does Omeprazole, 40 mg o.m., Improve Antimicrobial Therapy Directed Towards Gastric Campylobacter pylori in Patients with Antral Gastritis?Scandinavian Journal of Gastroenterology, 1989
- "ERADICATION" OF CAMPYLOBACTER PYLORI: ARE WE BEING MISLED?The Lancet, 1988
- Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Journal of Clinical Pathology, 1988
- Monotherapy or Polychemotherapy in the Treatment ofCampylobacter pylori-Related Gastroduodenal DiseaseScandinavian Journal of Gastroenterology, 1988
- The Efficacy of Antimicrobial Treatment inCampylobacter pylori-associated Gastritis and Duodenal UlcerScandinavian Journal of Gastroenterology, 1988
- Antibiotic sensitivity of ”Campylobacter pylori“European Journal of Clinical Microbiology & Infectious Diseases, 1984